Pharma-sector context
Consider product, site, supply chain and commercial roles together.
CONSUMER REGULATORY SERVICES SERVICES
Pharmaceutical Regulatory Advisory
Align pharmaceutical product, facility and market plans with the regulatory responsibilities that apply at each stage.
Licence coordination
Plan the relevant product and facility application workstreams.
Quality and compliance
Connect regulatory records with quality and operating responsibilities.
Change management
Review changes to products, sites and suppliers for regulatory impact.
SERVICE OVERVIEW
A joined-up view of product, site and supply chain
An informed regulatory plan starts with the facts of your product, activity and operating model.
Pharmaceutical regulation can involve product status, manufacturing or import permissions, quality systems, pricing controls, labelling and distribution practices. Requirements depend on the product and the role performed by each entity.
Astronis supports the regulatory work plan and coordination of records across business and technical teams. Product safety, quality decisions and scientific evidence must be confirmed by the responsible qualified personnel and relevant authorities.
OUR SERVICES
How we support pharmaceutical
A coordinated set of regulatory workstreams, tailored to the activity, evidence and outcomes you need to address.
Product and activity mapping
Document product categories and the proposed manufacturing, import, marketing or distribution roles.
Licensing and application support
Coordinate facility and product documentation for the applicable review pathway.
Pricing and market questions
Identify pricing-control and market-related questions for specialist assessment.
Ongoing compliance planning
Organise records and review points for changes, renewals and continuing obligations.
REGULATORY LANDSCAPE
Know the framework behind each decision.
A pharmaceutical business can engage several frameworks at once. Applicability depends on product status, activity, site and current orders; specialist confirmation is essential.
Talk to our regulatory teamKEY LAWS & FRAMEWORKS
A considered view of pharmaceutical regulatory advisory
The specific rules, notifications and authority directions should be confirmed for each matter.
Drugs and Cosmetics Act, 1940
The core statutory framework for drugs, together with applicable rules and amendments.
Drugs Rules, 1945
Requirements relevant to drug manufacture, sale, distribution and licensing.
New Drugs and Clinical Trials Rules, 2019
A framework relevant to new drugs and clinical trials where applicable.
Drug price-control framework
The Essential Commodities Act and applicable DPCO orders and notifications may be relevant to pricing.
WHO WE ASSIST
Support shaped around your role
We work with organisations and stakeholders navigating pharmaceutical regulatory advisory questions at different stages of operation.
Pharmaceutical manufacturers
Manufacturers, loan licensees and contract manufacturing partners.
Importers and marketers
Businesses responsible for importing, marketing or product authorisations.
Wholesalers and distributors
Supply-chain participants managing storage and distribution.
Investors and licensees
Stakeholders assessing a product portfolio, facility or pharma transaction.
OUR APPROACH
A clear process from assessment to follow-through
Each engagement is scoped to the relevant activity, available records and decision milestones.
- 01
Inventory products and sites
Create a fact base covering products, facilities, activities and counterparties.
- 02
Identify regulatory scope
Map product, licence, pricing and quality questions that need confirmation.
- 03
Set the evidence plan
Assign owners for technical records, quality materials and application information.
- 04
Coordinate submissions
Support document readiness, filing coordination and authority follow-up.
- 05
Embed ongoing review
Track conditions, renewals and changes across product and facility records.
KEY CONSIDERATIONS
Plan for the details that shape compliance
Addressing these points early can help reduce avoidable delays and keep responsibilities clear.
Product portfolio requires segmentation
Different product categories may follow different routes and controls.
Quality evidence is foundational
Regulatory records should remain consistent with validated operating documents.
Pricing controls may apply
Product status and applicable notifications should be checked for price-control implications.
Supply-chain roles matter
Contracts and actual operating responsibilities should align with the compliance map.
SERVICE-SPECIFIC VIEW
Pharmaceutical activity and its regulatory lens
Use this high-level guide to organise the initial review. Applicability depends on the facts and current requirements.
| Business activity | Primary review lens | Operational evidence |
|---|---|---|
| Manufacture | Product category, site and manufacturing permissions | Facility, quality and product records |
| Import | Product status, import route and local responsibilities | Product dossier, supplier and import documents |
| Marketing | Authorisation, claims, pricing and label responsibilities | Approved product and promotional records |
| Distribution | Applicable sale permissions, storage and traceability | Premises, inventory and distribution records |
This summary is for general information and does not replace advice on a specific product, project or regulatory matter.
INSIGHTS & RESOURCES
Explore all insights Keep informed as requirements evolve
Explore further information and discuss how current regulatory developments may affect your organisation.
INSIGHTS
Regulatory updates and perspectives
Read the latest commentary and updates from Astronis Global.
Explore insights KNOWLEDGE CENTREGuidance for regulatory decisions
Browse information to help frame your next compliance question.
Visit knowledge centre BUSINESS GUIDESPractical resources for your team
Explore available guides and identify the right next step for your business.
Browse business guidesFREQUENTLY ASKED QUESTIONS
Have another question? Contact us Pharmaceutical Regulatory Advisory: common questions
Answers to help you frame an initial conversation. The applicable position should be confirmed for your circumstances.
Is the pharmaceutical pathway the same as the general drugs advisory pathway?
The frameworks overlap, but this service focuses on pharmaceutical product portfolios, sites, supply chains and commercial responsibilities. The applicable route still depends on the specific product and activity.
Do pharmaceutical products have the same pricing obligations?
No. Pricing controls depend on the product and the current statutory and notification framework. A product-specific review is needed.
Can you advise on clinical and quality decisions?
We can coordinate the regulatory workstream and identify records needed. Scientific, clinical and quality determinations should be made by qualified specialists.
How should we manage changes to an approved product or facility?
Maintain a change-control review that checks the product, site, supplier and permission conditions before implementation, then update relevant records as required.
LET'S DISCUSS YOUR REQUIREMENTS
Move forward with a clearer regulatory plan.
Tell us about your organisation, activity and the regulatory question you need to address.
TESTIMONIALS
Clear advice. Practical direction.
Perspectives shared with permission by clients of our advisory teams.
Astronis Global brought clarity and commercial focus to a complex restructuring exercise. Their advice was practical, timely and easy for our leadership team to act on.
The team understood our regulatory requirements quickly and helped us move forward with confidence. We valued their responsiveness and disciplined follow-through.
Astronis Global provided dependable support across multiple registrations and approvals. Their communication was clear, structured and consistently professional.